FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Maria Isabel de José

Research Profile

Disorders

Procedures

Living Beings

Concepts & Ideas

Chemicals & Drugs

Geographic Areas

Spain

Physiology

Viral Drug Resistance

Co-author Network

Publications

TOP 3
Luis Manuel Prieto; José Tomás Ramos; Miguel Angel Roa; María José Santos; Beatriz Soto; José Beceiro; Irene Cuadrado; Maria Isabel de José; Teresa Del Rosal; María Fernández-Ibieta; María I González Tomé; David Lora; Eloy Muñoz; M Luisa Navarro
Low rates of mother-to-child transmission of HIV-1 and risk factors for infection in Spain: 2000-2007.
Verónica Briz; Maria Isabel de José; Miguel de Mulder; Dolores García; María I González Tomé; Manuel Leal; Juan A León-Leal; Ma José Mellado; Gema Méndez-Lagares; David Moreno-Pérez; M Luisa Navarro; José Tomás Ramos; Ezequiel Ruiz-Mateos; M Angeles Muñoz-Fernández
High prevalence of X4/DM-tropic variants in children and adolescents infected with HIV-1 by vertical transmission.
Raquel Vecino; Gema Muñoz; Gerardo Prieto; Begoña Santiago; Fernando Baquero-Artigao; Maria Isabel de José; Carmen García; Goosen Luis López; Ana Martínez; Asunción Mejías
Tuberculosis in pediatric solid organ and hematopoietic stem cell transplant recipients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Maria Isabel de José (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Luis Manuel Prieto; José Tomás Ramos; Miguel Angel Roa; María José Santos; Beatriz Soto; José Beceiro; Irene Cuadrado; Maria Isabel de José; Teresa Del Rosal; María Fernández-Ibieta; María I González Tomé; David Lora; Eloy Muñoz; M Luisa Navarro
Low rates of mother-to-child transmission of HIV-1 and risk factors for infection in Spain: 2000-2007.
The Pediatric infectious disease journal 2012;31(10):1053-8.
2012: Verónica Briz; Maria Isabel de José; Miguel de Mulder; Dolores García; María I González Tomé; Manuel Leal; Juan A León-Leal; Ma José Mellado; Gema Méndez-Lagares; David Moreno-Pérez; M Luisa Navarro; José Tomás Ramos; Ezequiel Ruiz-Mateos; M Angeles Muñoz-Fernández
High prevalence of X4/DM-tropic variants in children and adolescents infected with HIV-1 by vertical transmission.
The Pediatric infectious disease journal 2012;31(10):1048-52.
2012: Raquel Vecino; Gema Muñoz; Gerardo Prieto; Begoña Santiago; Fernando Baquero-Artigao; Maria Isabel de José; Carmen García; Goosen Luis López; Ana Martínez; Asunción Mejías
Tuberculosis in pediatric solid organ and hematopoietic stem cell transplant recipients.
The Pediatric infectious disease journal 2012;31(7):774-7.
2012: Verónica Briz; Maria Isabel de José; Santiago J de Ory; María I González Tomé; Manuel Leal; Juan A León-Leal; César Gavilán Martín; David Moreno-Perez; Claudia Palladino; Itziar Pocheville; José Tomás Ramos; Ma Ángeles Muñoz-Fernández
Potent and sustained antiviral response of raltegravir-based highly active antiretroviral therapy in HIV type 1-infected children and adolescents.
The Pediatric infectious disease journal 2012;31(3):273-7.
2012: Sara Guillén; Santiago Jiménez de Ory; María José Mellado; María Ángeles Muñoz; M Luisa Navarro; Luis Prieto; Miguel Ángel Roa; José Tomás Ramos; José Beceiro; Maria Isabel de José; Ignacio González-Granado; María I González Tomé
[New diagnosis of HIV infection in children].
Enfermedades infecciosas y microbiología clínica 2012;30(3):131-6.
2012: Miguel de Mulder; Santiago Jiménez de Ory; María I González Tomé; María Dolores Gurbindo; Africa Holguín; María José Mellado; María Ángeles Muñoz-Fernández; Adriana Navas; José Tomás Ramos; Jesús Saavedra-Lozano; Gonzalo Yebra; Maria Isabel de José
High drug resistance prevalence among vertically HIV-infected patients transferred from pediatric care to adult units in Spain.
PloS one 2012;7(12):e52155.
2012: Marta Dapena; Francisco Javier Aracil; Concepción Figueras; Claudia Fortuny; Beatriz Jiménez; Rebeca Lahoz; Antoni Noguera Julian; Pere Soler-Palacín; Maria Isabel de José
Metabolic disorders in vertically HIV-infected children: future adults at risk for cardiovascular disease.
Journal of pediatric endocrinology & metabolism : JPEM 2012;25(5-6):529-35.
2011: V Briz; Maria Isabel de José; Mi González-Tomé; S Jiménez de Ory; Ja León; Ml Navarro; E Núñez-Cuadros; C Palladino; Jt Ramos; Ma Muñoz-Fernández
Etravirine-based highly active antiretroviral therapy in HIV-1-infected paediatric patients.
HIV medicine 2011;12(7):442-6.
2010: Salvador Resino; Claudia Palladino; Raquel Lorente; Dariela Micheloud; Jose Maria Bellón; Beatriz Larru; Maria Dolores Gurbindo Gutiérrez; Maria Isabel de José; Rosa Polo; M Angeles Muñoz-Fernández
Association between lipodystrophy and leptin in human immunodeficiency virus-1-infected children receiving lopinavir/ritonavir-based therapy.
The Pediatric infectious disease journal 2010;29(8):774-7.
2010: Claudia Palladino; Verónica Briz; Sergio Negre Policarpo; Laura Fernandez Silveira; Maria Isabel de José; M Isabel González-Tomé; David Moreno; Juan A León Leal; Ma José Mellado; Santiago J de Ory; José Tomás Ramos; M Angeles Muñoz-Fernández
Long-term efficacy and safety of fosamprenavir in human immunodeficiency virus-infected pediatric patients.
The Pediatric infectious disease journal 2010;29(6):563-6.
2008: Salvador Resino; Dariela Micheloud; Beatriz Larrú; José M Bellón; Juan Antonio Léon; Rosa Resino; Maria Isabel de José; Maria Dolores Gurbindo Gutiérrez; Ma José Mellado; Sara Guillen; José Tomás Ramos; M Angeles Muñoz-Fernández
Immunological recovery and metabolic disorders in severe immunodeficiency HIV type 1-infected children on highly active antiretroviral therapy.
AIDS research and human retroviruses 2008;24(12):1477-84.
2008: Claudia Palladino; José M Bellón; Santiago Perez-Hoyos; Rosa Resino; Sara Guillén; Dolores Garcia; María Dolores Gurbindo; José Tomás Ramos; Maria Isabel de José; Ma José Mellado; M Angeles Muñoz-Fernández
Spatial pattern of HIV-1 mother-to-child-transmission in Madrid (Spain) from 1980 till now: demographic and socioeconomic factors.
AIDS (London, England) 2008;22(16):2199-205.
2008: Beatriz Larrú; Salvador Resino; José M Bellón; Maria Isabel de José; Claudia Fortuny; M Luisa Navarro; María Dolores Gurbindo; José Tomás Ramos; Pere Soler Palacín; Juan Antonio Léon; Manuel Asensi; Ma José Mellado; M Angeles Muñoz-Fernández
Long-term response to highly active antiretroviral therapy with lopinavir/ritonavir in pre-treated vertically HIV-infected children.
The Journal of antimicrobial chemotherapy 2008;61(1):183-90.
2007: Dariela Micheloud; Julia Jensen; José M Bellón; Dolores Gurbindo; Maria Isabel de José; David Moreno; José Tomás Ramos; M Angeles Muñoz-Fernández; Salvador Resino
Slow progression of human immunodeficiency virus and hepatitis C virus disease in a cohort of coinfected children.
The Pediatric infectious disease journal 2007;26(9):846-9.
2007: B Larrú Martínez; Maria Isabel de José; J María Bellón; María Dolores Gurbindo; Juan Antonio León; Luis Ciria; José Tomás Ramos; Ma José Mellado; Itziar Pocheville; José Luis Jiménez; M Angeles Muñoz-Fernández
[Prevalence of resistance to antiretroviral drugs in Spain].
Anales de pediatría (Barcelona, Spain : 2003) 2007;67(2):104-8.
2007: Mireya Orío; Jose Peña; M Teresa Rives; Mario Sanz; Isabel Bates; Rosario Madero; Maria Isabel de José
[Changes in vertical HIV transmission: comparison between 1994 and 2004].
Medicina clínica 2007;128(9):321-4.
2007: Beatriz Larru; Carmen de Mendoza; José M Bellón; Maria Isabel de José; Ma José Mellado; Vincent Soriano; Ma Angeles Muñoz-Fernandez; José Tomás Ramos
Predictive factors of virological success to salvage regimens containing protease inhibitors in HIV-1 infected children.
BMC infectious diseases 2007;7():55.
2006: Jesús Saavedra-Lozano; José Tomás Ramos; Francisco Sanz; M Luisa Navarro; Maria Isabel de José; Pablo Martín-Fontelos; Ma José Mellado; Juan A León Leal; Cecilia Rodriguez; Isabel Luque; Samuel J Madison; David Irlbeck; E Randall Lanier; Octavio Ramilo
Salvage therapy with abacavir and other reverse transcriptase inhibitors for human immunodeficiency-associated encephalopathy.
The Pediatric infectious disease journal 2006;25(12):1142-52.
2006: Salvador Resino; Rosa Resino; José Maria Bellón; Dariela Micheloud; Maria Dolores Gurbindo Gutiérrez; Maria Isabel de José; José Tomás Ramos; Pablo Martín Fontelos; Luis Ciria; M Angeles Muñoz-Fernández
Clinical outcomes improve with highly active antiretroviral therapy in vertically HIV type-1-infected children.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;43(2):243-52.
2006: Salvador Resino; Alejandro Alvaro-Meca; Maria Isabel de José; Pablo Martin-Fontelos; Maria Dolores Gurbindo Gutiérrez; Juan Antonio Léon; José Tomás Ramos; Luis Ciria; M Angeles Muñoz-Fernández
Low immunologic response to highly active antiretroviral therapy in naive vertically human immunodeficiency virus type 1-infected children with severe immunodeficiency.
The Pediatric infectious disease journal 2006;25(4):365-8.
2006: Salvador Resino; Beatriz Larrú; Jose Maria Bellón; Rosa Resino; Maria Isabel de José; Marisa Navarro; Juan Antonio Léon; José Tomás Ramos; Ma José Mellado; M Angeles Muñoz-Fernández
Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children.
BMC infectious diseases 2006;6():107.
2005: José Tomás Ramos; Maria Isabel de José; Joaquín Dueñas; Claudia Fortuny; Raúl González-Montero; Ma José Mellado; Antonio Mur; Marisa Navarro; Carmen Otero; Itziar Pocheville; M Angeles Muñoz-Fernández; Esther Cabrero
Safety and antiviral response at 12 months of lopinavir/ritonavir therapy in human immunodeficiency virus-1-infected children experienced with three classes of antiretrovirals.
The Pediatric infectious disease journal 2005;24(10):867-73.
2005: Salvador Resino; Isabel Galán; Alicia Pérez; José Tomás Ramos; José M Bellón; Pablo Martín Fontelos; Maria Isabel de José; Maria Dolores Gurbindo Gutiérrez; Esther Cabrero; M Angeles Muñoz-Fernández
Immunological changes after highly active antiretroviral therapy with lopinavir-ritonavir in heavily pretreated HIV-infected children.
AIDS research and human retroviruses 2005;21(5):398-406.
2005: José Tomás Ramos; Maria Isabel de José; Rosa Polo; Claudia Fortuny; Ma José Mellado; M Angeles Muñoz-Fernández; José Beceiro; José María Bertrán; Cristina Calvo; Lourdes Chamorro; Luis Ciria; Sara Guillén; Raúl González-Montero; María I González Tomé; María Dolores Gurbindo; Pablo Martín-Fontelos; Jorge Martínez-Pérez; David Moreno; María Carmen Muñoz-Almagro; Antonio Mur; M Luisa Navarro; Carmen Otero; Pablo Rojo; Bárbara Rubio; Jesús Saavedra
[Recommendations of the CEVIHP/SEIP/AEP/PNS on antiretroviral treatment in HIV-infected children and teenagers].
Enfermedades infecciosas y microbiología clínica 2005;23(5):279-312.
2005: Salvador Resino; Alejandro Alvaro-Meca; Maria Isabel de José; María Dolores Gurbindo; José Tomás Ramos; Pablo Martin-Fontelos; M Angeles Muñoz-Fernández
Lopinavir/r versus nelfinavir as salvage therapy.
The Pediatric infectious disease journal 2005;24(4):392-3.
2004: Salvador Resino; José M Bellón; José Tomás Ramos; Milagros Gonzalez-Rivera; Maria Isabel de José; Ma Isabel González; Dolores Gurbindo; Ma José Mellado; Esther Cabrero; M Angeles Muñoz-Fernández
Positive virological outcome after lopinavir/ritonavir salvage therapy in protease inhibitor-experienced HIV-1-infected children: a prospective cohort study.
The Journal of antimicrobial chemotherapy 2004;54(5):921-31.
2004: Salvador Resino; José M Bellón; José Tomás Ramos; Rosa Resino; María Dolores Gurbindo; Ma José Mellado; Maria Isabel de José; M Angeles Muñoz-Fernández
Impact of highly active antiretroviral therapy on CD4+ T cells and viral load of children with AIDS: a population-based study.
AIDS research and human retroviruses 2004;20(9):927-31.
2004: Salvador Resino; José Ma Bellon; Rosa Resino; M Luisa Navarro; José Tomás Ramos; Maria Isabel de José; Ma José Mellado; M Angeles Muñoz-Fernández
Extensive implementation of highly active antiretroviral therapy shows great effect on survival and surrogate markers in vertically HIV-infected children.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38(11):1605-12.
2004: Isabel Galán; José Luis Jiménez; Milagros González-Rivera; Maria Isabel de José; M Luisa Navarro; José Tomás Ramos; Ma José Mellado; María Dolores Gurbindo; José M Bellón; Salvador Resino; Esther Cabrero; M Angeles Muñoz-Fernández
Virological phenotype switches under salvage therapy with lopinavir-ritonavir in heavily pretreated HIV-1 vertically infected children.
AIDS (London, England) 2004;18(2):247-55.
2002: Carmen de Mendoza; José Tomás Ramos; Luis Ciria; Claudia Fortuny; Francisco José García; Maria Isabel de José; Francisco Asensi; Vincent Soriano
Efficacy and safety of stavudine plus didanosine in asymptomatic HIV-infected children with plasma HIV RNA below 50,000 copies per milliliter.
HIV clinical trials 2002;3(1):9-16.
2001: José A Iribarren; José Tomás Ramos; Luis Guerra; Oriol Coll; Maria Isabel de José; P Domingo; Claudia Fortuny; Pilar Miralles; Francisco Parras; Jose Peña; C Rodrigo; R Vidal
[Prevention of vertical transmission and treatment of infection caused by the human immunodeficiency virus in the pregnant woman. Recommendations of the Study Group for AIDS, Infectious Diseases, and Clinical Microbiology, the Spanish Pediatric Association, the National AIDS Plan and the Spanish Gynecology and Obstetrics Society].
Enfermedades infecciosas y microbiología clínica 2001;19(7):314-35.
1997: Jesús Ruiz Contreras; José Tomás Ramos; T Hernández-Sampelayo; Maria Isabel de José; Julián Clemente; María Dolores Gurbindo
Campylobacter sepsis in human immunodeficiency virus-infected children. The Madrid HIV Pediatric Infection Collaborative Study Group.
The Pediatric infectious disease journal 1997;16(2):251-3.